ReviewPsychoneuroendocrinology2026
Considerations and practical recommendations for identifying perimenopause in longitudinal research.
Review in Psychoneuroendocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Approximately half of the global population will live to experience the menopausal transition, which is associated with significant quality of life concerns and economic costs. Due to research and funding inequities, there exist significant gaps in knowledge about the menopausal transition and how to improve health outcomes. One tool that is needed to push women's health research forward is the ability to prospectively and accurately identify reproductive stage throughout the female lifespan. In the current paper we review the current criteria for reproductive staging and historical research methods of determining stage, including retrospective and prospective approaches. We discuss important considerations surrounding recall intervals, limitations of the 2011 Stages of Reproductive Aging Workshop + 10 (STRAW+10) criteria, and data privacy concerns. We provide recommendations for the design and execution of future studies, including digital data processing algorithms that can clearly implement operational definitions of STRAW+ 10 reproductive stages. Standardizing STRAW+ 10 terminology and validating methods to collect, process, and analyze prospectively tracked vaginal bleeding data will facilitate more precise and reliable reproductive staging that are critically needed to increase our understanding of how perimenopause increases risk for adverse health outcomes and develop novel interventions to increase quality of life during reproductive aging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.